Cellular Biomedicine Group Inc.

Addressing unmet medical needs of the world's largest population, Cellular Biomedicine Group is a biomedicine firm engaged in the development of effective cellular therapies for degenerative joint diseases and airway diseases, immuno-oncology drugs for various cancers, as well as providing biomedical and cellular technical services to healthcare facilities in China. Led by a seasoned management team and board with more than 150 years of relevant experience in China, Europe, and the USA, it is the only pure-play NASDAQ-listed China market-focused biomedicine developmental company.